N@N

Cord Blood America, Inc.: Cord Blood America Now Part of New ETF Innovators Stem Cell Index

^{Published on 2009-02-09 08:47:00, Last Modified on 2009-02-09 08:47:36 - Market Wire}
 

SANTA MONICA, CA--(Marketwire - February 9, 2009) - Cord Blood America, Inc. (OTCBB: [ CBAI ]), the umbilical [ cord blood ][ stem cell ] preservation company ([ http://www.cordblood-america.com ]) focused on bringing the life saving potential of [ stem cells ] to families nationwide and internationally, said today that the Company is now listed on the [ ETF Innovators Emerging Stem Cell Index of U.S.-listed stocks ]. For more information, see the social media news room at [ http://www.intelligendo.com ].

[ ETF Innovators ], known for creating new global equity indexes with a focus in the healthcare industry, will track the total market value and stock price changes as an indicator of investor and trader sentiment toward the stem cell and [ regenerative medicine ] space.

"We are pleased by this recognition. Two thousand and nine has been, so far, both very interesting and positive for stem cell companies, and we're pleased to see this impressive index following our sector," said Matthew Schissler, Founder and CEO of Cord Blood America.

About Cord Blood America

Cord Blood America (OTCBB: [ CBAI ]) is the parent company of CorCell, which facilitates umbilical cord blood stem cell preservation for expectant parents and their children. Its mission is to be the most respected stem cell preservation company in the industry. Collected through a safe and non-invasive process, cord blood stem cells offer a powerful and potentially life-saving resource for treating a growing number of ailments, including cancer, leukemia, blood, and immune disorders. To find out more about Cord Blood America, Inc. (OTCBB: [ CBAI ]), visit our website at [ www.corcell.com ]. For investor information, visit [ www.cordblood-america.com ].